2017-10-19

[#DIV28SUPER] NIDA Neuroscience Update, October 19, 2017

Table of Contents

I.                  Meet NIDA Staff at the Annual Meeting for Society For Neuroscience, Nov 10-16, 2017

II.               Exploiting HIV and/or Host Genomic Information to Understand HIV Compartments or Reactivation in Individuals with Substance Use Disorders (R61/R33) (RFA-DA-18-016)  Application Receipt Date:  December 13, 2017 by 5 pm local time of applicant organization.

III.              Request for Information (RFI): Seeking Input from Surgeons and Interventionalists on Improving the Clinical Study and Use of New and Established Peripheral Neuromodulation Devices  NOT-RM-17-023

IV.              Request for Information: Trans-NIH Strategic Plan for Research on Women’s Health

I.  Come meet NIDA Staff at the Annual Meeting Society for Neuroscience, Nov 10-16, 2017.  NIDA staff will be at the NIDA-NIAAA Mini-Convention, Friday Nov 10, 2017 Walter E. Washington Convention Center, Rm 207A, Washington, DC and at the NIDA Booth. To make an appointment with NIDA Staff to discuss a proposal or funding opportunities see email addresses below. 

Division of Neuroscience and Behavior

Office of the Director

email

telephone

Rita Valentino, Ph.D. Director

valentinorj@nida.nih.gov

301-827-5436

Roger Little, Ph.D. Deputy Director

alittle@nida.nih.gov

301-435-1316

Steven Grant, Ph.D. Coordinator for Translation, Cognitive Neuroscience, Neuroimaging

sgrant@nida.nih.gov

301-443-8869

Training

Beth Babecki, M.A., Lead coordinator: Training Hub, Basic F30, F31, F32, T32

bbabecki@mail.nih.gov

301-435-0899

Mary Kautz, Ph.D. Program Director: Clinical, T32

kautzm@nida.nih.gov

301-443-3206

Roger Sorenson, Ph.D., M.P.A., Program Director:  Basic K99/R00

rsorense@nida.nih.gov

301-443-3205

Yu (Woody) Lin, Ph.D., M.D. Program Director: Clinical K99/R00

ylin1@nida.nih.gov

301-435-1318

Behavioral and Cognitive Neuroscience Branch

Mary Kautz, Ph.D., Acting Chief,  TRSP Liason Behavioral Pharmacology, Nicotine

kautzm@nida.nih.gov

301-443-3206

Cora Lee Wetherington, Ph.D. Program Director: Women and Sex/Gender Differences- Research Coordinator; Sex/Gender Differences, Vulnerability, Development

cwetheri@nida.nih.gov

301-435-1319

Zu-In (Shelly) Su, Ph.D. Program Director: Cognition, Affect, Operant Behavior

shelley.su@nih.gov

301-402-3869

Integrative Neuroscience Branch

Roger Sorensen, Ph.D. , M.P.A., Chief, Molecular and Cellular Neurobiology, Neural Circuits, Glia

rsorense@nida.nih.gov

301-443-3205

Olivier Berton, Ph.D. Program Director: Cells, Circuits & Neuroplasticity in Motivation and Addiction

olivier.berton@nih.gov

301-827-7771

Vani Pariyadath, Ph.D., Program Director: Cognitive Neuroscience, Neuroimaging of addiction-related circuitry

pariyadathv@nida.nih.gov

301-443-3209

Vishnudutt Purohitt, D.V.M., Ph.D., Program Director: HIV, Inflammation and Immune System, Pain

vpurohit@nida.nih.gov

301-594-5753

Yu (Woody) Lin, Ph.D., Porgram Director: Cognitive Neuroscience, Neuro Aids, Pain, CNS Plasticity, Neuromodulation

ylin1@nida.nih.gov

301-435-1318

Chemistry, Pharmacology, and Physiological Systems Branch

Rao Rapaka, Ph.D. Chief, Medicinal Chemistry, Nanotechnology, ADME(PK//PD) and Systems Biology (proteomics, metabolomics, tyrptomics, Lipidomics, etc)

rrapaka@mail.nih.gov

301-435-1304

Kristopher Bough, Ph.D., Program Director and SBIR/STTR Division Coordinator: Basic Drug Discovery Program

boughk@nida.nih.gov

301-443-9800

Paul Hillery, Ph.D., Program Director: Organic and Medicinal Chemistry, Structural Biology

phillery@mail.nih.gov

301-435-1306

Genetics, Epigenetics, and Developmental Neuroscience Branch

Jonathan D. Pollock, Ph.D., Chief, Molecular Neuroanatomy, Genetics of Addiction, Molecular Basis of Memory, Molecular Genetics or Host Response

jpollock@mail.nih.gov

301-435-1309

Amy Lossie, Ph.D., Program Director: Bioinformatics, Statistical Genetics, Transposable Elements, Splicing, RNA binding Proteins.

amy.lossie@nih.gov

301-435-1308

John Satterlee, Program Director: Epigenetics, Non-coding RNAs, Model Organism Genetics, Functional Genomics, Signal Transduction

satterleej@mail.nih.gov

301-435-1020

Da-Yu Wu, Program Director: Neural Development, Gene Regulation

wudy@mail.nih.gov

301-435-4649

 

II. Exploiting HIV and/or Host Genomic Information to Understand HIV Compartments or Reactivation in Individuals with Substance Use Disorders (R61/R33)
(RFA-DA-18-016)  Application Receipt Date:  December 13, 2017 by 5 pm local time of applicant organization.

  • Purpose:  This initiative will support exploratory projects that exploit HIV or host genomic or nucleomic information to understand HIV latency in individuals with substance use disorders (SUDs).

 

  • NIDA intends to commit $2 million dollars in FY2018 to fund 3-4 awards

 

  • Application budgets are limited to $650,000 direct costs and must reflect the actual needs of the proposed project.

 

  • The R61/R33 grant mechanism includes an exploratory high risk/high pay off R61 phase (three years).  Near the end of the R61 phase, NIDA scientific staff will review progress made towards the proposed R61 milestones and recommend a subset of R61 projects for continued support through the R33 phase (two years) pending merit and the availability of funds

 

  • Nucleomics:  robust nuclear architecture assays (e.g. Hi-C, ChIA-PET, DamID, cellular imaging approaches) 

 

 

III. Request for Information (RFI): Seeking Input from Surgeons and Interventionalists on Improving the Clinical Study and Use of New and Established Peripheral Neuromodulation Devices  NOT-RM-17-023: The NIH SPARC (Stimulating Peripheral Activity to Relieve Conditions) program aims to enable the development of the next generation of neuromodulation devices informed by promoting the systematic development of high resolution neural circuit maps within organs and tissues of the peripheral nervous system. Therapeutic development may be stimulated by increasing the understanding of human peripheral neuroanatomy and its relationship to organ function, which may be facilitated by stronger linkages between clinical practice and basic research. To guide future efforts, SPARC is requesting input from surgeons, interventionalists, and other relevant clinicians on partnering to improve the clinical study of neuromodulation devices, specifically in applications involving peripheral or spinal neuromodulation of organ function. Comments should be provided by 1 December 2017.

 

IV.Request for Information: Trans-NIH Strategic Plan for Research on Women’s Health

The NIH Office of Research on Women’s Health has published a Request for Information (RFI) on the next Trans-NIH Strategic Plan for Research on Women’s Health.  It can be found in the NIH Guide (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-17-108.html).  A link within the RFI will take you to a form where you can submit your ideas.  Feedback is sought on 3 cross-cutting themes and goals under consideration:  (1) Expand the Exploration of Sex as a Biological Variable (SABV) in NIH Research, (2) A Multi-Dimensional Approach to the Science of Women's Health, and  (3) Quality of Life and Disease Burden over the Life-Course.  Your feedback is requested by November 10.

 

 The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov   301-435-1309

 

No comments:

Post a Comment